Empowered Antibodies Congress 2012
13th June 2012 — 14th June 2012
3 Co-located Conferences: Bispecifics and Multivalent Antibodies Antibody-Drug Conjugates Engineered Antibodies
With the growing phenomina of engineering antibodies to enhance function, potency, stability and specific targeting, Informa Life Sciences' would like to welcome you to Europe's leading platform for industry, academia and technology providers. The Empowered Antibodies Congress provides unrivalled networking opportunities and the chance to discuss the latest techniques for improvement/enhancement, antibody platforms and preclinical/clinical updates on production of these next generation products.
The congress enables you to access professionals in the 3 key antibody universes to discover the latest scientific know-how, benchmark against cutting-edge engineering technologies and the opportunity to hear the latest industry bottlenecks in development.
Conference highlights for 2012: Essential feedback from the authorities plus practical advice from industry to help ensure REACH compliance:
- Network with 150+ scientists working ith novel antibody formats including bispecifics, ADCs and alternative fragments
- Access 3 conferences in 1 and maximise your profile across 3 delegate audiences
- Get involved in high speed networking to make more business contacts in one session than you can make in 6 months!
- Key focuses on some of the hottest topics in the antibody arena: Engineering tools, clinical updates on applications of bispecifics & novel therapeutic targets, manufacturability and developability issues of all next generation products
Expected Number of Attendees
View Conference Website: Empowered Antibodies Congress 2012
Price of Attendance
Hotel Palace Berlin
Budapester Straße 45